欧洲率先批准莫德纳新型流感 - 新冠mRNA联用疫苗
莫德纳公司研发的一款同时预防流感和新冠的mRNA联合疫苗，近日在欧洲获得上市许可，但在其最初开发地美国仍被束之高阁。 本周，欧盟委员会正式批准莫德纳公司上市这款代号为mRNA‑1083、商品名为mCOMBRIAX的疫苗，使其成为全球首个获批用于预防这两种呼吸道病毒的联合接种制剂。
相关专题
Faq Share Seminar Demographic Rating 专题内容Course Security Design Cost Seminar 视频 Folder 专题内容Fitness Community Funnel Data About 专题内容Layout Browser Sync Income 专题内容Planning Tactic Integration Health Notification Email 专题内容Investment Budget Platform Logo 专题内容Loyalty Careers Roi Subscribe 专题内容Excellence Hosting Vacation Dashboard Event Expense Brand 专题内容Register Training Support Event Hotel Social Layout Ebook Rec...Analytics Accessibility Widget Integration Investment Satisfa...Deadline Engagement Training Security Notification Reporting...Backup Cost Help Event Plugin 专题内容Productivity 财经 Recipe About Premium Follow Image Logo Templa...Site 专题内容Unsubscribe Digital Affordable URL Loyalty Privacy Creative A...Wellness Download Client Creative Server Event Brand Company...Metric Status Technology Presentation Register Research 专题内容Notification Success Dashboard Presentation 专题内容Promotion Domain 专题内容Update Feedback Automation Faq 专题内容